A POSTnote outlining the challenges in developing new drugs to treat dementia, and an overview of UK and international research activities to accelerate progress.Jump to full report >>
Dementia Infographic - Public Health England
Dementia is a syndrome characterised by progressive damage to nerve cells in the brain causing loss of cognitive function. Symptoms worsen over time and 24-hour care is needed in the latter stages.
At least 800,000 people in the UK have dementia and it costs £26.3bn per year in health and social care costs (fig 1), more than cancer and heart disease combined. The number of people with dementia and associated costs are predicted to more than double by 2050.
There are no licensed drugs that stop or slow the progression of dementia. UK Dementia policy in recent years has resulted in increased funding to advance treatment and care. Find out more about the Government's approach to tackling dementia on its dementia topic page.
The key points in this POSTnote are:
Authors: Sarah Bunn; Nadia Marks
The Parliamentary Office of Science and Technology produces independent, balanced and accessible briefings on public policy issues related to science and technology.